APA (7th ed.) Citation

BV, L., U, V., MM, T., M, N., MC, C., M, G., . . . T, S. (2026). Polθ activity modulates sensitivity to standard therapies in DNMT3A-deficient leukemia. Cell reports. Medicine, 7(3), 102687. https://doi.org/10.1016/j.xcrm.2026.102687

Chicago Style (17th ed.) Citation

BV, Le, et al. "Polθ Activity Modulates Sensitivity to Standard Therapies in DNMT3A-deficient Leukemia." Cell Reports. Medicine 7, no. 3 (2026): 102687. https://doi.org/10.1016/j.xcrm.2026.102687.

MLA (9th ed.) Citation

BV, Le, et al. "Polθ Activity Modulates Sensitivity to Standard Therapies in DNMT3A-deficient Leukemia." Cell Reports. Medicine, vol. 7, no. 3, 2026, p. 102687, https://doi.org/10.1016/j.xcrm.2026.102687.